Fortress Diagnostics

Gel card format assays for blood grouping and transfusion compatibility testing.

Point-of-care and rapid-format tests for a range of febrile and other antigen/antibody targets.

Catalogued quality control products and documentation to support laboratory QA/QC programmes.

Urine test strips detecting Ascorbic Acid, Urobilinogen, Blood, Ketone, Glucose, Protein, pH, Bilirubin, Nitrite, SG, Leucocytes.

Urine test strips detecting Urobilinogen, Blood, Ketone, Glucose, Protein, pH, Bilirubin, Nitrite, SG, Leucocytes.

Fortress Serum Indices are quality controls designed to monitor instrument detection of lipaemia, icterus, and haemolysis in specimens, aiding in the identification of pre-analytical interferences in clinical laboratories.

Intended for in vitro diagnostic use in the quality control of urine on clinical chemistry systems.

Intended for in vitro diagnostic use in the quality control of urine on clinical chemistry systems.

Intended for in vitro diagnostic use in the quality control of urine on clinical chemistry systems.

Set of lyophilised human serum based controls, intended for laboratory use to monitor precision and accuracy of substrates, electrolytes and enzymes testing procedures.

Lyophilised human serum based control, intended for laboratory use to monitor precision and accuracy of substrates, electrolytes and enzymes testing procedures.

Lyophilised human serum based control, intended for laboratory use to monitor precision and accuracy of substrates, electrolytes and enzymes testing procedures.

Lyophilised human serum based control, intended for laboratory use to monitor precision and accuracy of substrates, electrolytes and enzymes testing procedures.

Calibration serum intended for use in automated analyzers, provided in a 5 x 3ml kit size.

Set of human based, lyophilized quality control materials covering levels 1 to 3 for monitoring laboratory performance in immunoassay test procedures such as RIA, EIA, ELISA, or FIA.

Human based, lyophilized quality control material for monitoring laboratory performance in immunoassay test procedures such as RIA, EIA, ELISA, or FIA.

Human based, lyophilized quality control material for monitoring laboratory performance in immunoassay test procedures such as RIA, EIA, ELISA, or FIA.

Human based, lyophilized quality control material for monitoring laboratory performance in immunoassay test procedures such as RIA, EIA, ELISA, or FIA.

A calibrator intended for use in assessing the accuracy and precision of Oxalate (Urinary) assays.

A quality control material for Oxalate (Urinary) assays at level 1 concentration.

A quality control material for Oxalate (Urinary) assays at level 2 concentration.

Ready to use clinical chemistry reagent with components R1: 2 x 60ml, R4: 1 x 5ml, stored at +2-8°C with R1 stability 14 days, R2 stability 28 days, R3 expiry at +2-8°C, range up to 27.4 U/l at 340nm.

Clinical chemistry reagent with R1: 6 x 60ml, R4: 1 x 5ml, stored at room temperature up to 25°C with 60 days stability once opened, range 0.17 - 6 g/dl.

Fortress Diagnostics Haematology Control Level 2 intended for use in monitoring the accuracy and precision of blood cell counts on Haematology analysers.

Fortress Diagnostics Haematology Control Level 3 intended for use in monitoring the accuracy and precision of blood cell counts on Haematology analysers.

Kit intended for use in monitoring the accuracy and precision of blood cell counts on haematology analysers.

Clinical chemistry reagent with R3: 3 x 10ml and R4: 1 x 5ml, stored at +2-8°C with 5 days onboard stability, range 1 - 90 U/l.

Clinical chemistry reagent with R1: 1 x 35ml, R2: 10 x 3ml, R3: 5 x 3ml, R4: 1 x 5ml, stored at +2-8°C with 30 days onboard stability, range 0 - 210 U/l.

Clinical chemistry reagent with R1: 1 x 105ml, R2: 10 x 10ml, R3: 5 x 10ml, R4: 1 x 5ml, lyophilized form.

Clinical chemistry reagent for use with Technicon RA Series analyzers, supplied as R1: 1 x 65ml and R2: 6 x 10ml.

Creatinine reagent suitable for Hitachi 917 analyser, used to measure creatinine levels indicating renal function impairment.

The Fortress Diagnostics Chlamydia Test is intended for in vitro diagnostic use in the rapid, qualitative detection of Chlamydia trachomatis directly from female endocervical swab, male urethral swab, male urine specimens, and ocular specimens. The test is intended for use as an aid in the diagnosis of Chlamydia infections.

Immunoturbidimetric assay for measuring Apolipoprotein A1 without sample predilution, linearity up to 300 mg/dl.

Apolipoprotein reagent suitable for Olympus System AU600, AU400, AU640, AU2700 analysers, used for early detection and assessment of coronary risk and diagnosis of apolipoproteinopathy.

Apolipoprotein reagent suitable for Hitachi 917 analyser, used for early detection and assessment of coronary risk and diagnosis of apolipoproteinopathy.

Creatinine Jaffe reagent suitable for Olympus System AU600, AU400, AU640, AU2700 analysers, used to measure creatinine levels indicating renal function impairment.

Immunoturbidimetric assay for measuring Apolipoprotein B without sample predilution, linearity up to 300 mg/dl.

Apolipoprotein reagent suitable for Olympus System AU600, AU400, AU640, AU2700 analysers, used for early detection and assessment of coronary risk and diagnosis of apolipoproteinopathy.

Apolipoprotein reagent suitable for Hitachi 917 analyser, used for early detection and assessment of coronary risk and diagnosis of apolipoproteinopathy.

Direct selective protection reagent for measuring LDL cholesterol, producing a blue color measured at 600nm.

Reagent for LDL cholesterol measurement by precipitation with heparin, HDL and VLDL remain in supernatant.

Combo rapid test cassette for simultaneous detection of Influenza and COVID-19 antigens using nasal swab samples, results in 15 minutes.

Combo rapid test cassette for simultaneous detection of Influenza and COVID-19 antigens using nasopharyngeal swab samples, results in 15 minutes.

Provides the detection of subgroups of A and variants of D on the same gel card. Identifies DVI- weak reactive and partial variants of D but not the VI variant of D directly. Identifies DVI+ reactive, variant of DVI includes D variants and weak D’s. Identifies the erythrocytes of antibody Rh DVI directly.

Identifies ABO and Rh D groups by using gel method. One card involves 2 tests and includes control well.

Identifies ABO and Rh D groups by using gel method. One card involves 2 tests. Does not include control well, instead includes AB.

Provides Coombs test (DAT) directly, Coombs test (IAT), compatibility, antibody screening and determining tests indirectly. All wells include Polyspecific anti-human globulin. The gel card for forward grouping and Cross-match. Detects ABO, Rh mismatch, and antibodies against donor or patient erythrocytes.

Provides Indirect Coombs test (IAT), compatibility, antibody screening and determining tests indirectly. Determines erythrocytes sensitized in vivo with IgG or complement C3d. Includes IgG well monospecific Anti-IgG, C3d well Anti human C3, AHG well Polyspecific anti-human globulin.

A urine strip test with 11 parameters for diagnostic use in liver disease assessment.

Fortress Diagnostics' quality control range Seraqual is utilised in laboratories across the world for accurate results you can rely on. Designed and manufactured in-house to the highest quality standards, these controls offer a wide parameter range allowing more analyte coverage in a single control and are highly compatible, mimicking human samples with minimal matrix effects.

A range of clinical chemistry reagents, analyser specific reagents, rapid tests, controls and calibrators to aid in renal function testing.

The Fortress hCG serum control is intended for use in assessing the precision and accuracy of hCG assays.

Elevated level lipid control material, available in lyophilised format.

Low level control material for Lipoprotein (a) assays, available in liquid format.

Calibrator for HDL and LDL cholesterol assays, available in lyophilised format.

Fortress Diagnostics Haematology Calibrator intended for use in monitoring the accuracy and precision of blood cell counts on Haematology analysers.

Clinical chemistry reagent for ALT measurement using IFCC UV kinetic method, available in multiple formats including lyophilized and liquid stable.

Calibrator for Lipoprotein (a) assays, available in liquid format.

Control set designed for validation of Fortress range of Syphilis Test Kits, including positive and negative controls for each test run.

Clinical chemistry reagent for alkaline phosphatase measurement, available in lyophilized and liquid stable formats.

Reagent for measuring triglycerides using GPO PAP methodology, available in liquid and lyophilised formats.

Reagent for measuring total cholesterol using CHOD PAP methodology, available in liquid and lyophilised formats.

Clinical chemistry reagent for ammonia measurement, supplied in mono format with components R1 and R4.

Creatinine reagent suitable for CA 180/270/400 Furuno/ Daytona Series analysers, used to measure creatinine levels indicating renal function impairment.

Clinical chemistry reagent with R1: 1 x 20ml, R2: 1 x 10ml, R4: 1 x 1ml, stored at 15 to 25°C with 12 weeks stability, range 0.17 - 6 g/dl.

Apolipoprotein reagent suitable for CA 180/270/400 Furuno/ Daytona Series analysers, used for early detection and assessment of coronary risk and diagnosis of apolipoproteinopathy.

Apolipoprotein reagent suitable for CA 180/270/400 Furuno/ Daytona Series analysers, used for early detection and assessment of coronary risk and diagnosis of apolipoproteinopathy.

Apolipoprotein reagent suitable for CA 180/270/400 Furuno/ Daytona Series analysers, used for early detection and assessment of coronary risk and diagnosis of apolipoproteinopathy.

Apolipoprotein reagent suitable for CA 180/270/400 Furuno/ Daytona Series analysers, used for early detection and assessment of coronary risk and diagnosis of apolipoproteinopathy.

Apolipoprotein reagent suitable for CA 180/270/400 Furuno/ Daytona Series analysers, used for early detection and assessment of coronary risk and diagnosis of apolipoproteinopathy.

Apolipoprotein reagent suitable for CA 180/270/400 Furuno/ Daytona Series analysers, used for early detection and assessment of coronary risk and diagnosis of apolipoproteinopathy.

Creatinine enzymatic reagent suitable for Olympus System AU600, AU400, AU640, AU2700 analysers, used to measure creatinine levels indicating renal function impairment.

A non-treponemal serological test for the detection of syphilis antibodies using a particulate carbon suspension coated with lipid complexes that agglutinates in the presence of serum reagins.

A non-treponemal flocculation test for detection and titration of reagins using VDRL Cardiolipin solution composed of cardiolipin, lecithin and cholesterol.

A sensitive and specific indirect haemagglutination test for detection of antibodies to Treponema Pallidum using preserved avian erythrocytes coated with antigen components.

RT-PCR kit for SARS-CoV-2 detection with 96 reactions per kit, suitable for laboratory testing.

Provides the detection of ABO, Rh D, Rh D VI and reverse grouping on one gel card. Identifies DVI- weak reactive and partial variants of D but not the VI variant of D directly. Identifies DVI+ reactive, variant of DVI includes D variants and weak D’s. Identifies the erythrocytes of antibody Rh DVI directly. Uses A1 and B cells for reverse apply in the last two wells.

Provides identifying of Rh and K antibodies which have clinical importance by gel method. Applies ABO, RH D, Rh D VI and direct Coombs test on newborns on one gel card. AHG well involves Polyclonal anti-IgG and monoclonal C3 antibodies, IgG well involves monospecific Anti-IgG antibodies.

Provides compatibility tests using gel method.

RNA extraction kit for PCR testing, available in different kit sizes for laboratory use.